Microvessels support engraftment and functionality of human islets and hESC-derived pancreatic progenitors in diabetes models.

Cell Stem Cell

McEwen Stem Cell Institute, University Health Network, Toronto, ON M5G 1L7, Canada; Deparment of Physiology, University of Toronto, Toronto, ON M5S 1A8, Canada. Electronic address:

Published: November 2021

Islet transplantation is a promising treatment for type 1 diabetes (T1D), yet the low donor pool, poor islet engraftment, and life-long immunosuppression prevent it from becoming the standard of care. Human embryonic stem cell (hESC)-derived pancreatic cells could eliminate donor shortages, but interventions to improve graft survival are needed. Here, we enhanced subcutaneous engraftment by employing a unique vascularization strategy based on ready-made microvessels (MVs) isolated from the adipose tissue. This resulted in improved cell survival and effective glucose response of both human islets and hESC-derived pancreatic cells, which ameliorated preexisting diabetes in three mouse models of T1D.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.stem.2021.08.001DOI Listing

Publication Analysis

Top Keywords

hesc-derived pancreatic
12
human islets
8
islets hesc-derived
8
pancreatic cells
8
microvessels support
4
support engraftment
4
engraftment functionality
4
functionality human
4
pancreatic progenitors
4
progenitors diabetes
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!